Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the perception of the physicians and the patients about the approved
adjustable dosing of Symbicort® 160/4,5. Symbicort maintenance dose will be adjusted up and
down within the approved dose range of 1x2 - 4x2 inhalations per day, to the level of asthma
symptoms. Patients and physicians perception of this new dosing schedule will be evaluated by
means of questionnaires completion and direct questioning.